Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global GMP Biologics Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by GMP Biologics Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global GMP Biologics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Monoclonal Antibodies
    • 1.4.3 Polyclonal Antibody
  • 1.5 Market by Application
    • 1.5.1 Global GMP Biologics Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals
    • 1.5.3 Clinics
    • 1.5.4 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): GMP Biologics Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the GMP Biologics Industry
      • 1.6.1.1 GMP Biologics Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and GMP Biologics Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for GMP Biologics Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 GMP Biologics Market Perspective (2015-2026)
  • 2.2 GMP Biologics Growth Trends by Regions
    • 2.2.1 GMP Biologics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 GMP Biologics Historic Market Share by Regions (2015-2020)
    • 2.2.3 GMP Biologics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 GMP Biologics Market Growth Strategy
    • 2.3.6 Primary Interviews with Key GMP Biologics Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top GMP Biologics Players by Market Size
    • 3.1.1 Global Top GMP Biologics Players by Revenue (2015-2020)
    • 3.1.2 Global GMP Biologics Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global GMP Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global GMP Biologics Market Concentration Ratio
    • 3.2.1 Global GMP Biologics Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by GMP Biologics Revenue in 2019
  • 3.3 GMP Biologics Key Players Head office and Area Served
  • 3.4 Key Players GMP Biologics Product Solution and Service
  • 3.5 Date of Enter into GMP Biologics Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global GMP Biologics Historic Market Size by Type (2015-2020)
  • 4.2 Global GMP Biologics Forecasted Market Size by Type (2021-2026)

5 GMP Biologics Breakdown Data by Application (2015-2026)

  • 5.1 Global GMP Biologics Market Size by Application (2015-2020)
  • 5.2 Global GMP Biologics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America GMP Biologics Market Size (2015-2020)
  • 6.2 GMP Biologics Key Players in North America (2019-2020)
  • 6.3 North America GMP Biologics Market Size by Type (2015-2020)
  • 6.4 North America GMP Biologics Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe GMP Biologics Market Size (2015-2020)
  • 7.2 GMP Biologics Key Players in Europe (2019-2020)
  • 7.3 Europe GMP Biologics Market Size by Type (2015-2020)
  • 7.4 Europe GMP Biologics Market Size by Application (2015-2020)

8 China

  • 8.1 China GMP Biologics Market Size (2015-2020)
  • 8.2 GMP Biologics Key Players in China (2019-2020)
  • 8.3 China GMP Biologics Market Size by Type (2015-2020)
  • 8.4 China GMP Biologics Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan GMP Biologics Market Size (2015-2020)
  • 9.2 GMP Biologics Key Players in Japan (2019-2020)
  • 9.3 Japan GMP Biologics Market Size by Type (2015-2020)
  • 9.4 Japan GMP Biologics Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia GMP Biologics Market Size (2015-2020)
  • 10.2 GMP Biologics Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia GMP Biologics Market Size by Type (2015-2020)
  • 10.4 Southeast Asia GMP Biologics Market Size by Application (2015-2020)

11 India

  • 11.1 India GMP Biologics Market Size (2015-2020)
  • 11.2 GMP Biologics Key Players in India (2019-2020)
  • 11.3 India GMP Biologics Market Size by Type (2015-2020)
  • 11.4 India GMP Biologics Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America GMP Biologics Market Size (2015-2020)
  • 12.2 GMP Biologics Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America GMP Biologics Market Size by Type (2015-2020)
  • 12.4 Central & South America GMP Biologics Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Creative Diagnostics
    • 13.1.1 Creative Diagnostics Company Details
    • 13.1.2 Creative Diagnostics Business Overview and Its Total Revenue
    • 13.1.3 Creative Diagnostics GMP Biologics Introduction
    • 13.1.4 Creative Diagnostics Revenue in GMP Biologics Business (2015-2020))
    • 13.1.5 Creative Diagnostics Recent Development
  • 13.2 Fisher Bioservices(Thermo Fisher Scientific)
    • 13.2.1 Fisher Bioservices(Thermo Fisher Scientific) Company Details
    • 13.2.2 Fisher Bioservices(Thermo Fisher Scientific) Business Overview and Its Total Revenue
    • 13.2.3 Fisher Bioservices(Thermo Fisher Scientific) GMP Biologics Introduction
    • 13.2.4 Fisher Bioservices(Thermo Fisher Scientific) Revenue in GMP Biologics Business (2015-2020)
    • 13.2.5 Fisher Bioservices(Thermo Fisher Scientific) Recent Development
  • 13.3 Polpharma Biologics
    • 13.3.1 Polpharma Biologics Company Details
    • 13.3.2 Polpharma Biologics Business Overview and Its Total Revenue
    • 13.3.3 Polpharma Biologics GMP Biologics Introduction
    • 13.3.4 Polpharma Biologics Revenue in GMP Biologics Business (2015-2020)
    • 13.3.5 Polpharma Biologics Recent Development
  • 13.4 Intertek
    • 13.4.1 Intertek Company Details
    • 13.4.2 Intertek Business Overview and Its Total Revenue
    • 13.4.3 Intertek GMP Biologics Introduction
    • 13.4.4 Intertek Revenue in GMP Biologics Business (2015-2020)
    • 13.4.5 Intertek Recent Development
  • 13.5 HemaCare
    • 13.5.1 HemaCare Company Details
    • 13.5.2 HemaCare Business Overview and Its Total Revenue
    • 13.5.3 HemaCare GMP Biologics Introduction
    • 13.5.4 HemaCare Revenue in GMP Biologics Business (2015-2020)
    • 13.5.5 HemaCare Recent Development
  • 13.6 AGC
    • 13.6.1 AGC Company Details
    • 13.6.2 AGC Business Overview and Its Total Revenue
    • 13.6.3 AGC GMP Biologics Introduction
    • 13.6.4 AGC Revenue in GMP Biologics Business (2015-2020)
    • 13.6.5 AGC Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global GMP Biologics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the GMP Biologics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    Creative Diagnostics
    Fisher Bioservices(Thermo Fisher Scientific)
    Polpharma Biologics
    Intertek
    HemaCare
    AGC
    ...

    Market segment by Type, the product can be split into
    Monoclonal Antibodies
    Polyclonal Antibody
    Market segment by Application, split into
    Hospitals
    Clinics
    Others

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global GMP Biologics status, future forecast, growth opportunity, key market and key players.
    To present the GMP Biologics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of GMP Biologics are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now